Thrombocytopoiesis in Hematopoietic Transplantation
造血移植中的血小板生成
基本信息
- 批准号:7647941
- 负责人:
- 金额:$ 12.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-07-04 至 2010-06-30
- 项目状态:已结题
- 来源:
- 关键词:AblationAddressAdvisory CommitteesAffectAntigen-Presenting CellsApoptosisApoptoticBloodBlood PlateletsBone Marrow TransplantationCXCR4 geneCancer CenterCell CycleCell TransplantationCellsClinical InvestigatorDataDefectDevelopmentDiseaseEngraftmentEnvironmentEvaluationExposure toFacultyGenesHematologic NeoplasmsHematopoieticHematopoietic Stem Cell TransplantationHematopoietic stem cellsHigh Dose ChemotherapyHomeostasisHomingHumanImmuneIn VitroMarrowMediatingMedicalMegakaryocytesMentorsMentorshipMesenchymal Stem CellsModelingMolecularMorbidity - disease rateMusNon obeseNon-MalignantParticipantPathway interactionsPhysiciansPlayPopulationPrincipal InvestigatorProgram DevelopmentRadiationRecoveryResearchRoleSCID MiceScientistStem cellsStressTNFRSF6 geneThrombocytopeniaThrombopoiesisTrainingTraining ProgramsTranslatingTransplantationXenograft procedureauthoritycareerchemokinechemotherapycytokinedesigndiabetichuman INPPL1 proteinimprovedin vivoinhibitor/antagonistmortalitynovel strategiespre-clinicalprogenitorprogramsreceptorreceptor expressionreconstitutionskillsstem cell biology
项目摘要
DESCRIPTION (provided by applicant): This proposal describes a training program for the development of an academic career in hematopoietic stem cell (HSC) transplantation. The principal investigator (PI) is a junior faculty of the Bone Marrow Transplant Program at H. Lee Moffitt Cancer Center. The PI will expand her scientific skills through training as participant of a Physician-Scientist mentorship program. Dr. Claudio Anasetti, Chief of the Bone Marrow Transplantation Program and an authority in hematopoietic cell transplantation, will mentor the principal investigator's scientific development. In addition, an advisory committee of highly regarded medical scientists will provide scientific and career advice. Prolonged thrombocytopenia after high dose chemotherapy is a problem associated with increased morbidity and mortality. The proposed research will provide preclinical data on novel strategies to improve platelet reconstitution post transplant. Dr. Perez proposes to study the thrombopoietic role of in vitro generated megakaryocytes in a xenotransplantation model for human megakaryocytopoiesis. In vivo approaches to improve their function with chemokines and/or accessory cells will be studied. Research on apoptotic mechanism affecting engraftment of cycling HSC that may translate on improved homing, engraftment and differentiation of in vitro cytokine stimulated HSC to generate megakaryocytes will be addressed. In addition, molecular studies of genes that may regulate megakaryocytopoiesis and participate in platelet recontitution will be studied. Moffitt Cancer Center has an extremely nurturing environment and provides an ideal setting for training physician scientists. Interactions between scientists, physician/scientists and clinical investigators maximizes the potential of the PI to establish a successful independent research program on hematopoietic stem cell biology and transplantation.
描述(由申请人提供):本提案描述了造血干细胞(HSC)移植学术生涯发展的培训计划。主要研究者(PI)是H.李莫菲特癌症中心。PI将通过培训作为物理学家-科学家导师计划的参与者来扩展她的科学技能。Claudio Anasetti博士是骨髓移植项目的负责人,也是造血细胞移植的权威,他将指导主要研究者的科学发展。此外,一个由德高望重的医学科学家组成的咨询委员会将提供科学和职业建议。大剂量化疗后持续性血小板减少是一个与发病率和死亡率增加相关的问题。这项研究将为改善移植后血小板重建的新策略提供临床前数据。Perez博士建议在异种移植模型中研究体外生成的巨核细胞在人类巨核细胞生成中的血小板生成作用。将研究用趋化因子和/或辅助细胞改善其功能的体内方法。影响周期性HSC植入的凋亡机制的研究可能会转化为体外细胞因子刺激的HSC产生巨核细胞的归巢,植入和分化的改善。此外,还将对可能调节巨核细胞生成和参与血小板重建的基因进行分子研究。莫菲特癌症中心有一个非常有利的环境,并提供了一个理想的环境,为培训医生科学家。科学家、医生/科学家和临床研究者之间的互动最大限度地发挥了PI的潜力,以建立一个成功的造血干细胞生物学和移植独立研究项目。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LIA ELENA PEREZ其他文献
LIA ELENA PEREZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LIA ELENA PEREZ', 18)}}的其他基金
Clonogenic Characterization of Myeloma Progenitor Cells
骨髓瘤祖细胞的克隆形成特征
- 批准号:
8104170 - 财政年份:2010
- 资助金额:
$ 12.74万 - 项目类别:
Clonogenic Characterization of Myeloma Progenitor Cells
骨髓瘤祖细胞的克隆形成特征
- 批准号:
7977423 - 财政年份:2010
- 资助金额:
$ 12.74万 - 项目类别:
Thrombocytopoiesis in Hematopoietic Transplantation
造血移植中的血小板生成
- 批准号:
7269793 - 财政年份:2005
- 资助金额:
$ 12.74万 - 项目类别:
Thrombocytopoiesis in Hematopoietic Transplantation
造血移植中的血小板生成
- 批准号:
7089988 - 财政年份:2005
- 资助金额:
$ 12.74万 - 项目类别:
Thrombocytopoiesis in Hematopoietic Transplantation
造血移植中的血小板生成
- 批准号:
6962136 - 财政年份:2005
- 资助金额:
$ 12.74万 - 项目类别:
Thrombocytopoiesis in Hematopoietic Transplantation
造血移植中的血小板生成
- 批准号:
7436317 - 财政年份:2005
- 资助金额:
$ 12.74万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 12.74万 - 项目类别:
Research Grant














{{item.name}}会员




